default author photo

Sisi Yang

Guizhou Medical University (Guiyang Medical University) - Department of Hematology

SCHOLARLY PAPERS

1

DOWNLOADS

65

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Venetoclax Combined with Daunorubicin and Cytarabine (2 + 6) as Induction Treatment in Adults with Newly Diagnosed Acute Myeloid Leukemia: A Phase 2, Multicenter Trial, Single-Arm Trial

Number of pages: 25 Posted: 07 Mar 2023
Handan Central Hospital - Department of Hematology, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Harrison International Peace Hospital - Department of Hematology, People Hospital of Xing Tai - Department of Hematology, People Hospital of Xing Tai - Department of Hematology, Sinopharm Tongmei General Hospital - Department of Hematology, Handan Central Hospital - Department of Hematology, Chengde Medical College - Department of Hematology, Handan Central Hospital - Department of Hematology, Handan Central Hospital - Department of Hematology, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, Harrison International Peace Hospital, Harrison International Peace Hospital, People Hospital of Xing Tai - Department of Hematology, Sinopharm Tongmei General Hospital - Department of Hematology, Guizhou Medical University (Guiyang Medical University) - Department of Hematology, First People's Hospital of Tianmen - Department of Hematology, Qingdao University - Department of Hepatology, Qingdao University - Department of Hepatology, First People's Hospital of Tianmen - Department of Hematology, Qingdao University - Department of Hepatology, Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology and Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC) - State Key Laboratory of Experimental Hematology
Downloads 65 (916,100)

Abstract:

Loading...

Venetoclax, daunorubicin and cytarabine, induction treatment, acute myeloid leukemia